Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...

(Reuters) -European shares climbed on Monday, recouping some of last week’s losses as Kering (EPA: PRTP) soared after the ...

Part of the appeal of amylin analogs is the potential to drive weight loss without causing the same level of tolerability problems as GLP-1 receptor agonists. Lilly reported relatively low rates of ...

European shares made cautious gains on Monday, with Gucci -owner Kering leading the pack following a leadership change. The ...

We have recently begun acquiring a new position in Novo Nordisk. Click here for our investment thesis on NVO stock.

Novo Nordisk has rebounded strongly in 2025, backed by solid financials despite earlier setbacks and competitive risks. See ...

Novo Nordisk’s annual report contains an interesting footnote on its key drug, Ozempic, which last year accounted for $19 ...

Novo Nordisk NVO shares have gained 5.8% in a week. The uptrend in the stock price was driven by reports of an activist hedge ...

STORY: Eli Lilly said Monday it will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying ...

Energy prices have jumped since the onset of clashes between Israel and Iran. Investors worry the conflict could have a big ...

ASX 200 futures are down 20ts (-0.23%) as of 8:30 am AEST. In a nutshell: US stocks tumbled as the Israel-Iran conflict ...